Press Release | Mon Apr 29, 2013 7:30am EDT

Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes

* Reuters is not responsible for the content in this press release.